🇺🇸 FDA
Patent

US 6610295

Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor

expired A61KA61K39/00

Quick answer

US patent 6610295 (Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor) held by Cogent Partners, LP expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Cogent Partners, LP
Grant date
Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K39/00